Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have inoperable (cannot be surgically removed) primary non-small cell lung cancer, or cancer that has spread to the lungs from elsewhere, and who have already been treated with a focused, high-dose radiation treatment called SBRT
- People whose cancer has come back in the same area (overlapping where the original radiation was aimed), confirmed by scans or tissue biopsy, within the chest
- People whose previous SBRT treatment used a radiation dose at or above a certain high level (biologically equivalent dose of 75 Gy or higher)
- People who are receiving a repeat course of focused, high-dose radiation (up to 8 sessions) aimed at eliminating the cancer
- People who either have no cancer that has spread to distant parts of the body, or whose distant spread is considered stable and controlled at the time of re-treatment
- People whose previous SBRT treatment was completed more than 12 months ago
- People who have a general health and activity level rated at 2 or below on a standard medical scale (meaning they are able to care for themselves but may not be able to do heavy physical work) (confirm with trial site)
Who may not be able to join:
- People who have previously received conventional (standard, non-focused) radiation therapy to the area
- People whose repeat radiation treatment is planned at lower, palliative doses (aimed at relieving symptoms rather than eliminating the cancer)
- People whose repeat radiation treatment uses a conventional or only mildly reduced fractionation schedule, rather than the high-dose, short-course approach used in this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 0282247428
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.